Abstract
Low‐fat diets were previously thought to be a key to achieving healthy weight; but higher fat and protein diets have also been shown to produce weight loss. The POUNDS LOST study was a randomized clinical trial which examined the effects of four calorie‐restricted diets of varying macronutrient composition on weight loss in free‐living adults with obesity. Participants were randomized to receive one of four diets: 1) 20% fat, 15% protein; 2)20% fat, 25% protein; 3) 40% fat, 15% protein; and 4) 40% fat, 25% protein. The objective of this analysis was to identify possible predictors of weight loss after 6 months including: diet type, dietary adherence, demographics, and dietary behaviors. Dietary adherence was defined as consuming within ± 5% of the target macronutrient composition for fat and protein. Three hundred forty‐five participants (54.8% female; 86.5% Caucasian, 12.4% African American, and 1.1% other) who provided baseline and 6‐month follow‐up data were included in the analyses. Stepwise regression and cross‐validation techniques were used to model weight loss as a function of all possible predictors. Average Squared Error was the primary model fit criterion by which the final model was selected; the following model fit criteria were also in agreement with the selection of the final model: Akaike information criterion (AIC), Corrected AIC, and Adjusted R‐Square. The following variables were retained: Age, dietary adherence, energy density change, and fiber intake. Mean weight loss was −8.4 ± 5.0 kg and did not vary across diet‐type. Energy density change was positively associated with weight change while age, dietary adherence, and fiber intake were inversely associated with weight change. Fiber intake was the strongest predictor; on average, a 10g increase in fiber intake was associated with 2.2kg decrease in body weight. These findings provide evidence for modifying dietary components like fiber and energy density to positively influence weight loss.Support or Funding InformationFunded by NIH‐NHLBI. ClinicalTrials.gov number, NCT00072995.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.